Table 1.
Patients, tumor and treatment characteristics.
| Value | % | |
|---|---|---|
| Number of patients | 25 | |
| Age | 55.1 ± 13.0 | |
| Sex (M:F) | 10 : 15 | 40% : 60% |
| Karnofksy index (%) | 81 ± 11 | |
| Peritoneal carcinomatosis index | ||
| mean | 15.3 ± 10.6 | |
| ⩽ 12 | 8 | 32% |
| >12 | 17 | 68% |
| Histology | ||
| - signet-ring | 22 | 88% |
| - intestinal | 3 | 12% |
| Ascites (ml) | ||
| mean | 493 ± 1192 | |
| ⩽300 | 18 | 72% |
| >300 | 7 | 28% |
| Previous chemotherapy lines | ||
| 1 | 25 | 100% |
| 2 | 16 | 64% |
| 3 | 5 | 20% |
| 4 | 2 | 8% |
| 5 | 2 | 8% |
| Previous surgery | ||
| Gastrectomy | 15 | 60% |
| Previous radiotherapy | 3 | 12% |
| Number of PIPAC cycles (n = 43) | ||
| 1 | 25 | 100% |
| 2 | 12 | 48% |
| 3 | 6 | 24% |
F, female; M, male; PIPAC, pressurized intraperitoneal aerosol chemotherapy.